In conclusion, the induction of EMT by EGF in MDA-MB-468 breast cancer cells is associated with alterations in the calcium signaling response to ATP and results in a cellular phenotype with an altered transcriptional profile of purinergic receptors, in particular an upregulation of P2X5. The gene discussed is P2RX3; the disease is breast cancer.